Upregulation of miR-192–5p has also been found to play a role in inhibiting metastatic potential of colon cancer by downregulating expression of Bcl-2, Zeb2 and VEGFA, factors that inhibit apoptosis and promote cell growth. Here, BCL2 is linked to colonic neoplasm.